Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 2 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 8 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZS | $38.8B | — | — | 11.6× | 25.4% | 76.8% | -1.9% | -2.4% | -2.4% | — | 232 |
| CTSH | $29.1B | 14.3× | 7.0× | 1.4× | 7.0% | — | 10.6% | 14.9% | 14.3% | -0.3× | 242 |
| EPAM | $7.2B | 20.9× | 10.4× | 1.3× | 15.4% | 28.8% | 6.9% | 10.3% | 10.2% | -2.2× | 107 |
| DOX | $6.6B | 14.8× | 9.1× | 1.3× | 2.4% | 35.1% | 9.9% | 14.3% | 12.0% | 0.4× | 101 |
| DOCS | $5.8B | 33.4× | 24.5× | 9.1× | 13.1% | 89.1% | 30.4% | 20.6% | 20.6% | -1.0× | 78 |
| ISSC | $444M | 28.2× | 19.5× | 5.3× | 78.6% | 48.1% | 18.5% | 24.2% | 17.6% | 0.9× | 19 |
| PERI | $359M | — | 97.1× | 0.8× | -11.7% | — | -1.8% | -1.2% | -1.2% | — | 11 |
| RDNW | $197M | — | 42.6× | 0.2× | -10.5% | 27.5% | -4.8% | 419% | -26.9% | — | 8 |
| AGMH | $2M | 1.6× | — | 0.1× | -4.6% | 10.3% | 1.8% | 1.4% | 1.4% | — | 1 |
Peers = companies sharing AGMH's sector (Services-Computer Programming Services) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 1 positive fiscal year (FY2024). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
The answer is outside the range this solves over (-60% to +100%/yr), so it is reported as off the scale rather than as a rate. The price is below what this cash flow is worth even under collapse.
Default is 10.0% — this company's computed cost of capital, the same rate the Analysis tab discounts at.
2-stage DCF · 0.00B shares (market data) · net debt -$325K
Today's price is outside this grid at every discount rate shown — the assumptions it requires lie beyond the plotted range, which is itself the finding.
mean 5.7% · volatility σ 271% · implied rate exceeded in 1/3 yrs
Central path = implied -60.0%/yr growth; shaded band = ±1σ (271%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$4.1M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.6M 100.0% | $32.0M 100.0% | $68.8M 100.0% | $203.1M 100.0% | $36.7M 100.0% | $53K 100.0% | $330K 100.0% | $5.1M 100.0% | $12.4M 100.0% | $6.9M 100.0% |
| Cost of Revenue | $27.4M 89.7% | $25.2M 78.6% | $65.6M 95.4% | $160.8M 79.2% | $30.1M 82.0% | $39K 72.3% | $43K 13.0% | $1.7M 32.3% | $3.3M 26.9% | $2.3M 33.4% |
| Cost of Products | — | — | — | — | — | — | — | — | $3.5M 28.5% | $2.4M 34.5% |
| Gross Profit | $3.2M 10.3% | $6.9M 21.4% | $3.2M 4.6% | $42.3M 20.8% | $6.6M 18.0% | $15K 27.7% | $287K 87.0% | $3.5M 67.7% | $9.1M 73.1% | $4.6M 66.6% |
| Research & Development | — | — | — | — | $36K 0.1% | $63K 119.0% | $127K 38.5% | $1.0M 20.1% | $398K 3.2% | $289K 4.2% |
| Selling, General & Admin | — | — | $13.9M 20.2% | $30.4M 15.0% | $1.6M 4.4% | $964K 1809.3% | $1.4M 415.1% | $3.9M 75.8% | $2.9M 23.6% | $1.8M 26.8% |
| Total Operating Expenses | $7.8M 25.6% | $909K 2.8% | -$12.7M -18.4% | $29.6M 14.6% | $1.6M 4.5% | $1.0M 1928.4% | $1.5M 453.6% | $5.8M 114.0% | $3.4M 27.1% | $2.1M 31.0% |
| Operating Income | -$4.7M -15.3% | $5.9M 18.6% | $15.8M 23.0% | $12.6M 6.2% | $5.0M 13.5% | -$1.0M -1900.7% | -$1.2M -366.6% | -$2.4M -46.3% | $5.7M 46.0% | $2.5M 35.6% |
| Interest Expense | — | — | $15K 0.0% | $5K 0.0% | $37K 0.1% | — | — | — | — | — |
| Other Income (Expense), net | $8.2M 26.7% | -$209K -0.7% | -$311K -0.5% | -$451K -0.2% | $4K 0.0% | -$8K -14.4% | -$211K -64.1% | -$13K -0.3% | $6K 0.0% | -$2K -0.0% |
| Pretax Income | $3.5M 11.4% | $5.7M 17.9% | $15.5M 22.6% | $12.2M 6.0% | $5.0M 13.5% | -$1.0M -1915.0% | -$1.4M -430.7% | -$2.4M -46.6% | $5.7M 46.0% | $2.4M 35.6% |
| Income Tax Expense | $2.9M 9.5% | $2.3M 7.3% | $4.1M 6.0% | $3.4M 1.7% | $1.4M 3.8% | $76K 143.2% | $65K 19.6% | -$595K -11.6% | $1.3M 10.5% | $783K 11.4% |
| Net Income | $562K 1.8% | $3.1M 9.7% | -$7.4M -10.8% | $11.5M 5.7% | $3.6M 9.7% | -$1.1M -2010.4% | -$1.6M -473.6% | -$8.4M -164.6% | $3.9M 31.4% | $2.4M 34.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.32 | $6.44 | -$15.33 | $0.47 | $0.17 | -$0.05 | -$0.07 | — | $0.19 | $13.48 |
| EPS (Diluted) | $0.32 | $6.44 | -$15.33 | $0.47 | $0.17 | -$0.05 | — | — | $0.19 | $13.48 |
| Weighted Avg Shares (Basic) | 1.8M | 485K | 485K | 24.3M | 21.5M | 21.8M | 21.3M | 21.0M | 20.0M | 174K |
| Weighted Avg Shares (Diluted) | 1.8M | 485K | 485K | 24.3M | 21.5M | 21.8M | — | 21.0M | 20.0M | 174K |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 8-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 8-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 1% against ROIC 1% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 38.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 32.3 | 13.0 | 72.3 | 82.0 | 79.2 | 95.4 | 78.6 | 89.7 |
| Gross Profit | 67.7 | 87.0 | 27.7 | 18.0 | 20.8 | 4.6 | 21.4 | 10.3 |
| R&D | 20.1 | 38.5 | 119.0 | 0.1 | — | — | — | — |
| SG&A | 75.8 | 415.1 | 1809.3 | 4.4 | 15.0 | 20.2 | — | — |
| Operating Income | -46.3 | -366.6 | -1900.7 | 13.5 | 6.2 | 23.0 | 18.6 | -15.3 |
| Income Tax | -11.6 | 19.6 | 143.2 | 3.8 | 1.7 | 6.0 | 7.3 | 9.5 |
| Net Income | -164.6 | -473.6 | -2010.4 | 9.7 | 5.7 | -10.8 | 9.7 | 1.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AGMH: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -60.61pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | -8.2% | 15.2% (today's — no rate published for this year) | -23.3pts |
| FY2020 | -23.4% | 15.2% (today's — no rate published for this year) | -38.6pts |
| FY2021 | 38.6% | 5.3% | 33.3pts |
| FY2022 | 28.6% | 9.3% | 19.3pts |
| FY2023 | 57.3% | 10.1% | 47.2pts |
| FY2024 | 19.5% | 15.2% (today's — no rate published for this year) | 4.3pts |
| FY2025 | -8.3% | 15.2% (today's — no rate published for this year) | -23.5pts |
| Now | 1.4% | 15.2% | -13.7pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 66.6% | 35.6% | 34.1% |
| FY2017 | 73.1% | 46.0% | 31.4% |
| FY2018 | 67.7% | -46.3% | -164.6% |
| FY2019 | 87.0% | -366.6% | -473.6% |
| FY2020 | 27.7% | -1900.7% | -2010.4% |
| FY2021 | 18.0% | 13.5% | 9.7% |
| FY2022 | 20.8% | 6.2% | 5.7% |
| FY2023 | 4.6% | 23.0% | -10.8% |
| FY2024 | 21.4% | 18.6% | 9.7% |
| FY2025 | 10.3% | -15.3% | 1.8% |
Return on equity (1%) and return on invested capital (1%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
ROIC ex-goodwill is -45.43% against -45.43% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Accruals are positive and DSO is up +134 days over 3 years — profit is being recognised ahead of collection.
Accruals are positive and DSO is up +134 days over 3 years. Either alone is explainable; together they are revenue recognised ahead of collection.
Missing from our data, so excluded from this answer: share_based_compensation.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda, interest_expense.
No growth rate within the range this model can express reaches the current price, so the requirement cannot be stated as a number.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: implied_growth.
| Step | Amount | Running total |
|---|---|---|
| Net income | $561,630 | $561,630 |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$5M | −$4M |
| Operating cash flow | −$4M | −$4M |
| Capex | $0 | −$4M |
| Free cash flow | −$4M | −$4M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -83.8% | not reported | not reported |
| FY2021 | 68767.7% | not reported | not reported |
| FY2022 | 453.3% | 3456.1% | 3002.9 points |
| FY2023 | -66.2% | -94.8% | -28.6 points |
| FY2024 | -53.4% | 175.4% | 228.8 points |
| FY2025 | -4.6% | 87.9% | 92.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 73.6 days | not reported | 27.2 days | 46.4 days |
| FY2020 | not reported | not reported | 47.1 days | not reported |
| FY2021 | 25.9 days | 271.9 days | 171.1 days | 126.7 days |
| FY2022 | 166.7 days | 8.9 days | 146.4 days | 29.2 days |
| FY2023 | 25.8 days | 30.6 days | 110.8 days | -54.4 days |
| FY2024 | 152.5 days | 393.8 days | 187.1 days | 359.1 days |
| FY2025 | 300.4 days | 77 days | 0.8 days | 376.5 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -9.4 percent |
| FY2020 | 9.3 percent |
| FY2021 | 6.1 percent |
| FY2022 | 23.0 percent |
| FY2023 | -5.9 percent |
| FY2024 | -6.5 percent |
| FY2025 | 10.5 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 3 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.